HIV-1 subtype C envelope-based peptide constructs as potential vaccine components.
The development of an effective HIV vaccine is hindered by several obstacles. One of the leading challenges is the antigenic variability of HIV-1 that is exhibited throughout all viral gene products but to greatest extent in the viral envelope proteins. This phenomenon is the result of continuous mu...
| Main Author: | |
|---|---|
| Published: |
2008
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10210/345 |